2nd Quarter - Report

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$2,330,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Homeland Security and Defense Issues Surrounding Readiness for a Chemical Nerve Agent Attack or Industrial Accident.

LobbyistCovered position, as disclosed
KEN W COLE —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Executive Office of the President (EOP); Commerce, Dept of (DOC); Food & Drug Administration (FDA); State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Alcohol and Drug Abuse ALC

Opioid Abuse Prescription Drug Abuse

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); State, Dept of (DOS)

Taxation/Internal Revenue Code TAX

Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 2280, The Offshoring Prevention Act H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1671, The Foreign Earnings Reinvestment Act S. 45, The Offshoring Prevention Act S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
CAROLINE MOODY SCHELLHAS —
MARY BRIDGET WALSH —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2495 (112th), S. 45 (112th), S. 1813 (112th), S. 1671 (112th), H.R. 2735 (112th), H.R. 2280 (112th), H.R. 4348 (112th), H.R. 1834 (112th)

Health Issues HCR

Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureaucrats Elimination Act, 2011

LobbyistCovered position, as disclosed
KEN W COLE —
JENNIFER DUCK —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Food & Drug Administration (FDA); Executive Office of the President (EOP)

Bills named: S. 668 (112th), S. 1734 (112th), H.R. 2182 (112th), H.R. 452 (112th)

Consumer Issues/Safety/Products CSP

Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Patent & Trademark Office (PTO); State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Animals ANI

E. coli Vaccine for Animals ELDU Ban on Cephalosporin H.R. 1406, Fairness to Pet Owners Act 2011

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —

Contacted: SENATE; Executive Office of the President (EOP); Patent & Trademark Office (PTO); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1406 (112th)

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); State, Dept of (DOS); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); State, Dept of (DOS); SENATE; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: State, Dept of (DOS); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.